|
NUFIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64330000052004E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.239910E-04 |
| Normal-vs-Stage2 |
5.104000E-02 |
| Normal-vs-Stage3 |
2.290100E-02 |
| Normal-vs-Stage4 |
1.352220E-01 |
| Stage1-vs-Stage2 |
6.567400E-01 |
| Stage1-vs-Stage3 |
8.738000E-01 |
| Stage1-vs-Stage4 |
6.493600E-01 |
| Stage2-vs-Stage3 |
8.141600E-01 |
| Stage2-vs-Stage4 |
9.331400E-01 |
| Stage3-vs-Stage4 |
7.690400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.99740000001492E-07 |
| Normal-vs-AfricanAmerican |
7.876300E-03 |
| Normal-vs-Asian |
1.817950E-02 |
| Caucasian-vs-AfricanAmerican |
3.613000E-01 |
| Caucasian-vs-Asian |
6.490000E-01 |
| AfricanAmerican-vs-Asian |
8.903200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.36749999996222E-06 |
| Normal-vs-Female |
1.81079999999056E-05 |
| Male-vs-Female |
1.992040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.139800E-02 |
| Normal-vs-Extreme_Weight |
1.049510E-02 |
| Normal-vs-Obese |
4.47810000000493E-05 |
| Normal-vs-Extreme_Obese |
5.342000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.485400E-01 |
| Normal_Weight-vs-Obese |
1.000840E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.675000E-01 |
| Extreme_Weight-vs-Obese |
8.059600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.983600E-01 |
| Obese-vs-Extreme_Obese |
9.401600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.825000E-04 |
| Normal-vs-Age(41-60Yrs) |
7.92120002923724E-09 |
| Normal-vs-Age(61-80Yrs) |
2.998600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.708800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.140800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.871600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.280300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.221500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.521700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.345220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.42739999819952E-08 |
| Normal-VS-Type2 PRCC |
2.679400E-01 |
| Normal-VS-KIRP CIMP |
1.858050E-02 |
| Normal-VS-Unclassified PRCC |
3.518300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.845100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.900200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.936800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.148100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.684300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.380200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.490300E-02 |
| Normal-vs-N1 |
6.636800E-03 |
| Normal-vs-N2 |
3.519400E-01 |
| N0-vs-N1 |
3.602200E-02 |
| N0-vs-N2 |
9.697000E-01 |
| N1-vs-N2 |
3.551200E-01 |
|
|
